Digital health innovations
We are actively seeking proven digital innovations that improve the health of people in the region and raise the quality, efficiency, safety and cost-effectiveness of delivering healthcare.
We are particularly interested to hear about innovations in the following categories:
  • Health maintenance - supporting people in maintaining their physical and mental wellbeing,
  • Prevention - alerting patients, carers or professionals when there are signs that things aren’t going well, and an intervention can prevent crises or emergencies
  • Access - providing more convenient and cost-effective ways for patients and professionals to interact. (e.g. remote monitoring or virtual consultations).
  • Learning and education - delivering information and knowledge to patients about their health or condition, or to professionals to support their continuous professional development
  • Pathways - providing tailored information to patients, carers and professionals on services to signpost people to the most appropriate place.  Ideally, this could be enhanced with real-time information about capacity.
  • Research - using digital tools to promote involvement in research & clinical trials, to streamline the capture of informed consent, and to capture research data more efficiently and conveniently.
  • Integration - tools that enable the secure, appropriate sharing of information between organisations (e.g. GPs and hospital clinicians) and sectors (e.g. NHS and Social Services) to allow patients to receive seamless care.
  • Data Visualisation - innovative ways of presenting information in a meaningful way to enable more informed decisions by patients and professionals.  This may involve aggregating data from different sources, reporting tools or graphic visualisations such as heat maps.

Ideas (Publish, Detailed Submission)

Innovation 'Elevator Pitch':
The Sound Doctor has over 250 high quality short educational films. Evaluations show they work by changing behaviours and improving outcomes to help people get the best out of life with long term conditions. 
Overview of Innovation:
The Sound Doctor is the leading provider of film and audio content for patients in the UK. Our content is thought to be unmatched in quality, range and production values and evaluations show it works by changing behaviours.and improving outcomes to help people get the best out of life with long term conditions.
 
Our films are endorsed by leading charities and adhere to NICE guidelines.
Conditions covered are COPD, Diabetes, back pain, dementia and weight management surgery.  A large series on heart conditions including cholesterol and hypertension, will be made shortly. 
There are over 250 films in our library so far and it is constantly growing.
We also create animations. We have a range of health and wellness short animations which are now being used in pharmacies and GP surgeries around the country. 
In addition, the team also devised and produce Health Today, a national radio programme for NHS England – nhs.uk/healthtodayradio
 
We have evidence that patients with diabetes, for example, have changed their attitudes towards diet and exercise as a result of watching our films. People with COPD are more confident about dealing with exacerbations at home. We also know that across all conditions they are considered a valuable part of people’s health care and improve patient experience.
 
The aims of The Sound Doctor, and there is evidence of this as well, are:
 
1. To reduce the number of avoidable admissions (and readmissions) to hospital
2. To reduce the need for face to face contact with consultants, physicians, nurses, physiotherapists and others (and to improve the quality of meetings which do take place)
3. To address the issue of co-morbidities by creating a multi-condition library
4. To improve medicines management and compliance with medications
5. To improve the quality of care for patients (and patient experience of their care)
6. To help people get the most out of life through effective self-management
   
About us:
The Sound Doctor was founded by Dominic Arkwright and Rosie Runciman and is a registered social enterprise.
Dominic worked as a reporter at the BBC for more than 20 years, mostly on Radio 4 's Today Programme as well as Newsnight and PM. He also presented discussion programme 'Off the Page' and 'The Call' on Radio 4.
Rosie Runciman also worked at the BBC for more than 20 years on Radio 4's Today programme, Newsnight, Radio 5 Live and at The World Service. She was Editor of Newshour and Assistant Editor at Five Live.
 
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Education, training and future workforce / Wealth creation / Digital health / Innovation and adoption / Patient and medicines safety / Person centred care
Benefit to NHS:
  • For clinicians 
    • Complements and supports sessions
    • Sessions more focused and efficient to achieve better health outcomes
    • Reduces appointments, admissions and DNAs
  • For providers 
    • More efficient caseloads, better outcomes for patients, reduced waiting lists
    • Money saved through reduced numbers of GP appointments, hospital admissions and DNAs
Return On Investment (GPs)
Cost of TSD per patient per annum = £5.00
 
Average number of GP visits pre TSD = 3.7 appointments Average number of GP visits post TSD = 0.42 appointments
 
3 fewer appointments per TSD user x payment for each appointment of
£23.50 (NHS tariffs) = £70.50 per patient; an ROI of 1:14
 
Average number of GP DNAs pre TSD = 2.5 appointments Average number of GP DNAs post TSD = 0.5 appointments
 
2 fewer DNAs per TSD user x cost of each DNA of £36 (Kings Fund) = £72 per patient; an ROI of 1:14
Initial Review Rating
3.80 (1 ratings)
Benefit to WM population:
Benefits for patients
  
  • Empowers and encourages people’s engagement with their condition
  
  • Improves medicines adherence
  
  • Improves overall quality of care
  
  • Improves people’s experience of and satisafaction with their care
Current and planned activity: 
Who’s using The Sound Doctor
•  CCGs 
  • Barnsley, Gloucestershire, West Leicester, Wirral, Newcastle, Central London Community Health Trust
  
  • Hospital Trusts 
    • Guy’s and Tommy’s NHS Trust
    • Liverpool Heart and Chest Hospital
  
  • Other 
    • Philips Healthcare
    • All South London pharmacies
    • Jhoots Pharmacies
    • NAPC Practice Innovation Network
    •  
 
What is the intellectual property status of your innovation?:
We own the IP on all our content
Return on Investment (£ Value): 
Very high
Return on Investment (Timescale): 
0-6 mon
Ease of scalability: 
Simple
Read more
Hide details
Dominic Arkwright 26/09/2016 - 15:02 Publish 1 comment
5
1
Votes
-99999
Innovation 'Elevator Pitch':
Sensely Ask NHS mobile app offering is a virtual nurse, Olivia, who guides the patient through clinical triaging or long term condition monitoring. Integrated and working with the NHS workforce. 
Overview of Innovation:
'Ask NHS' powered by Sensely provides patients and clinicians with improved access to NHS 111 and their local NHS services. Patients can talk through your symptoms in complete confidence with Nurse Olivia, a virtual nurse. If needed, Olivia she will arrange for a call back from a 111 Nurse to discuss symptoms further. Patients can also search NHS approved healthcare advice, schedule GP appointments and search opening times/locations of local healthcare services. It's the link for improving patient experience with Healthcare Providers and helping to cope with patient demand. Our key value proposition is to automate tasks for providers. We are Trusted , Empathetic, Personalised, Mobile First.

Sensely offers

- Mobile application platform that engages in natural conversations with patients.
- A clinician facing product which is data and process driven patient risk assessment.
- Direct Appointment Booking with GPs
- Service Locator (Integration with the NHS Directory of Services)
- Self Care Advice. Easily search through trusted NHS Choices healthcare advice and resources to gain a deeper understanding of conditions and treatments.
- Triage and Integration with Clinical Hubs (inc. NHS 111)
- Chronic Disease Management (CHF, COPD, Diabetes)

Olivia, our virtual nurse is connected with patients - 24/7 via their mobile device. She can help by answering their medical questions , measure their blood pressure, weight or glucose via blue tooth device, take a picture of their rash or swollen ankles and ask triage questions integrating with primary care services.

Olivia has been designed to embody the bedside manner of real healthcare professionals, and to be the clinician’s presence in patient’s life 24/7. Most importantly she does not only act as your virtual nurse - collecting vitals, scheduling appointments, offering health and wellness advice - she acts as your constant stream of accurate and clinically triaged information.

'Ask NHS' is powered by Sensely and delivered in collaboration with the NHS, NHS 111 and Odyssey by Advanced Healthcare. Visit http://www.sensely.com/asknhs to learn more.

For more information visit : http://www.asknhs.co.uk/ or email us at nhs@sensely.com
Stage of Development:
Close to market - Prototype near completion and final form may require additional validation/evaluation and all CE marking and regulatory requirements are in place
WMAHSN priorities and themes addressed: 
Mental Health: recovery, crisis and prevention / Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Education, training and future workforce / Digital health / Innovation and adoption / Patient and medicines safety / Person centred care
Benefit to NHS:
Key Benefits

1) Saving the Clinician time. Pre Appointment Triage / Screening of patients, helping to prioritise those who need to be seen urgently - acting as admission avoidance tool. Sensely also offers the ability to directly book / cancel appointments into EMIS Web practices helping users to make an appointment when needed. Sensely supports CCGs achieve patient online programme initiatives through collaborative working we're providing the complete solution - one bundled app to navigate UK healthcare.

2) Improve health data. Using data captured through wearables. Sensely helps capture data and readings e.g blood pressure and weight measurements which can be subsequently filed to the GP patient record. Through the use of GPSoC APIs - data is recorded in a standard format using Readcodes ensuring high quality data capture and future analysis.

3) Using Sensely on smartphones provides clinicians with an ever-present clinical decision support tool that ensures they are providing patients with the best care plans.

4) Improved Patient Care - 24/7. Always available. Users can use the app to monitor their health and understand their body better. Subsequently, through Senselys integrated offering - the platform can alert a clinician when a patient who is being remotely monitored is flagged at being at risk. In the US - Sensely is used for supporting Chronic Care Management.

5) Improved efficiency to urgent care delivery. NHS 111 currently receives approx 30,000 calls per day. At an average of £13/call. This equates to £390,000 per day. Through the use of Sensely Artificial Nurse - we believe we can deal with a percentage of the self care queries / calls which are dealt with by a non clinical advisor (approx 20%) for which we could help save the NHS a potential of £78,000 per day.

6) Sensely interfaces with the Directory of Services which is utilised by NHS 111. Through the use of Service Locator - both clinicians and public can locate the right service at the right time. The tool ensures visibility of new services is transparent as possible to the right user. It is simple to use, accurate - always available tool where the content is locally administered by commissioning dos leads.
Initial Review Rating
4.20 (2 ratings)
Benefit to WM population:
To solve the health industry operational problems, we created Sense.ly. Sense.ly is a mobile-first application platform that engages in natural conversations with patients to educate them, assess their medical conditions, answer their questions, and find the best possible sources of virtual assistance, telemedicine, or facility assistance. Our technology gives health providers and insurance companies the power to tailor unique customizable communication protocols and interaction workflows for each patient. The product offers the following capabilities:

1. Provides patients with a high quality “mobile virtual assistant” that proactively and reactively engages people in natural, personalized conversations and educational topics depending on their status, historical, and current issues.

2. Continuous monitoring of patients via mobile app

3. Connects patient/provider/payers with secure telemedicine and SMS platform

4. Delivers clinical, educational, and NHS/CCG information directly to the patient based on daily clinical picture, stage of treatment, claim progress, and immediate needs

5. Analyzes health data to calculate clinical improvement, compliance, readmission risk, and patient engagement.

6. Analyzes data-aggregates across disparate populations for the purposes of machine learning, disease prevention, risk/cost management, and clinical trials. Doctors and specialist use the information Sense.ly provides to optimize their team’s workflow around patients requiring immediate attention, while freeing up resources that would otherwise be allocated to less demanding cases.
Current and planned activity: 
Concept/Idea (No prototype, wireframes): Prescription Ordering

Working prototype developed (gathering feedback): Service Locator, Self Care, Direct Appointment Booking

Prototype with pilot users/clinical trials (test/validating): NHS 111 Odyssey Assessment integration with NHS 111, Medication Check

Prototype with paying customers: Patient Kiosk, Daily Check In

Fully developed product (paying customers, renewing contracts): Chronic Care Management
What is the intellectual property status of your innovation?:
The IP include 7 patent applications allowing us freedom to continuing to operate and innovate on our products and service lines by refining
our proprietary avatar conversation engine and clinical decision support system. The IP includes code, methods, and integrations defining the
conversation engine.
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
6-12 mon
Ease of scalability: 
Simple
Regulatory Approvals:
Please describe any current regulatory approvals you have achieved and how they were met/ in progress/planned.
Commercial information:
Please describe how the product/service is being developed commercially, whether in development, trials, pilot or full commercial delivery. Include the results you have from any market/demand surveys and forecasts . Please include any research you have on the broader commercial opportunity for the innovation both within the health sector nationally and internationally.
Investment activity:
Please describe what stage of investment you have reached and whether you are seeking additional rounds of investment. Please include cash investment as well as investment of soft assets such as access to specialist equipment, knowledge, trial base etc. and indicate the types/sources of your investment such as grants etc.
Regional Scalability:
Please describe how the innovation could be scaled across the WM region. Have you implemented at scale in any other regions?
Measures:
What outcomes are you hoping to achieve and what are the measures that you will use to gauge the success of the innovation and how will these assessments be made? Please ensure that you have quality, safety, cost and people measures.
Adoption target:
What are the targets for adoption across the WM and what are the minimum viability levels?
Investment sought:
What investment are you looking for in order to support wider adoption of this innovation and what have you managed to secure to date? Please provide a breakdown of these costs if possible.
Read more
Hide details
Anonymous 21/09/2016 - 13:58 Publish 1 comment
0
0
Votes
-99999
Innovation 'Elevator Pitch':

The NHS often does NOT know a patient’s wishes on treatment, their preferences or instructions. In a health emergency or mental crisis this information is vital.. MyDirectives gives everyone the chance to record their wishes in advance of a crisis.

Overview of Innovation:

MyDirectives.com and MyDirectives mobile gives every individual the opportunity to record their wishes for free. The service uses digitally delivered structured forms, video and audio messages to create high quality documents that health professionals trust to make best interest decisions. The service empowers individuals, allowing them to share their wishes with a close network of people (‘agents’) they trust to support them in a crisis or if they are unable to speak for themselves.  These ‘agents’ are sent instructional packs & urged to discuss preferences with the individuals concerned. MyDirectives then works with local health economies to integrate the person’s wishes & personal choices with primary, secondary and local authority databases & electronic health records so they can be confident their wishes & ‘digital voice’ will always be accessible & heard.
 
For health professionals this means they can be confident they are looking at the most up to date views of their patients, know who can speak for the patient & what their treatment choices & objectives are. This approach is both ‘human’ & from an innovation perspective, highly disruptive. It leads to faster, more appropriate & sensitive care decision making & can be easily scaled through MyDirectives' API to the whole care & health community.
 
The benefits of this pro-active approach are significant cash releasing savings that can be evidenced. An indication of how much this approach might save a health economy is a bill currently going though both houses of the US Congress that proposes to give every US citizen on Medicaid and Medicare £75 in return for creating a digital emergency, critical and advance care plan. MyDirectives has been live for four years and is used by individuals in 34 countries & is now looking for its first healthcare partner in the UK. 

We want a healthcare partner who can work with us to establish a UK integration network with GP suppliers, summary care record and organ donor lists and an adoption strategy using GP suppliers, secondary care providers, E-referrals, organ donor register and NHS Choices. We believe we can create a national system of adoption and retrieval using the NHS’ existing infrastructure. The end result will be a cost effective mechanism for recording and retrieving a patient's ‘voice’.

MyDirectives is the only company providing an integrated all digital solution to these issues.
 
See https://mydirectives for further details.

Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Mental Health: recovery, crisis and prevention / Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Wealth creation / Digital health / Innovation and adoption / Person centred care
Benefit to NHS:

ADVault has created an economic model for England that shows for every £1 spent on MyDirectives a health authority would save between £1.77 to £9.33 within five years. The variation depends on which NHS England figures you apply to the model. Please see attached five case national economic model created for HM Treasury for full details. The models are based on targeting the entire adult population of a health economy and capturing 25% of all deaths.

If the NHS were to set a 50% adoption level and the capture of 25% of all deaths within five years as achievable targets, it could expect to generate net savings of between £64,916,693 to £702,791,693 per annum by the end of year five. A city such as Birmingham could therefore expect to save c£6m a year.

These cost savings can be realised as individuals express in their Emergency, Critical and Advance Care Plans (ECACP) their preferences, wishes and goals for treatment and care that permit the NHS to intervene more appropriately and less intensively.  As a result, ECACPs lead to fewer people dying in hospital, reduced admissions, achieve shorter hospital stays, reduced unnecessary ambulance journeys, fewer ‘heroic’ treatment measures and fewer incidences of distressing and unwanted life-sustaining treatments.
 
With an ECACP there is also compelling evidence that carers return to work sooner following family health crises and bereavements and experience fewer subsequent mental health issues, as the end of life events are managed more sympathetically.  Anecdotal evidence suggests even more significant savings following unexpected accidents and trauma where an ECACP is in place.

MyDirectives is supported by the National Council for Palliative Care (CEO Claire Henry); Baroness Finlay, the Chair of the National Mental Capacity Forum and Professor Bee Wee, the National Director for End of Life Care.

We are currently looking for our first NHS partner.

Initial Review Rating
4.40 (2 ratings)
Benefit to WM population:

In addition to the benefits described in the previous section, we are looking for a regional partner such as a GP group, Trust or STP to showcase and then spread this innovation across the wider NHS. We would be comfortable to enter into a commercial arrangement to facilitate this partnership.
 
If a suitable regional partner can be identified, we would consider locating our UK business Headquarters in the West Midlands.
 
Given the health economic forecast described previously and the predictive benefits model for saving to NHS England a city such as Birmingham could expect to save approximately £6m a year.

Current and planned activity: 

ADVault, creators of MyDirectives, is looking for its first UK integration partner. In the USA our integration business is now operating successfully in 10 US States. In addition, we are also in discussions with the Australian Federal government.

We are seeking a regional partner such as a GP group, Trust or STP to showcase the product and then to spread this innovation across the wider NHS community.
 
We would be comfortable to enter into a commercial arrangement to facilitate this partnership
 
Should suitable regional partners be found, we would consider locating our UK business headquarters within the West Midlands.

What is the intellectual property status of your innovation?:

All the intellectual property is owned by ADVault Inc

Return on Investment (£ Value): 
Very high
Return on Investment (Timescale): 
3 years +
Ease of scalability: 
Simple
Regional Scalability:

MyDirectives can be scaled regionally or nationally. We generate better viral effects when we approach hundreds of thousands of people. This also "normalises" the process of recording you preferences, values and goals making success more likely. 

Measures:

Outcomes will be measured digitally based on volume of take up, retrieval and completion. We would also bring in researchers to look at impact on ambulance journeys, 111 decision making, medical crisis decision making, length of stay in hospital, organ donation rescind rate and deaths in normal place of residence.

Adoption target:

ADVault would seek to have 50% of a population signed up within five years. One of the consequence of this penetration would be that approx 25% of people in a community are likely to have one in place prior to a medical crisis.

Read more
Hide details
Jonathon Carr-Brown 27/07/2016 - 16:24 Detailed Submission Login or Register to post comments
0
0
Votes
-99999
Innovation 'Elevator Pitch':
Smartinhaler™ is an innovative electronic medication sensor that improves suboptimal medication use in patients with chronic respiratory diseases, including asthma and COPD. Our current focus is in asthma.
Overview of Innovation:
Poor medication adherence is one of the leading issues in the management of asthma and is thought to account for 34% of all asthma deaths (Royal College of Physicians, 2014) and treatment adherence to inhaled corticosteroids could reduce hospitalisation by 60% (Williams et al., 2004).
Smartinhaler™ (by Adherium Ltd) is a digital health solution to improve medication adherence in patients with chronic respiratory diseases. This is how it works: Smartinhaler™ clips onto an existing prescription inhaler. Once installed, the Smartinhaler™ device (1) periodically remind patients to take their medication, (2) records the date and time of inhaler use (independent of patient action), (3) transmits patient usage data to a mobile device and into Adherium’s cloud-based servers for patients and/or clinicians to review, and (4) provides warnings when the data indicate the patient’s disease may be escaping control.
The benefits of the Smartinhaler™ have been validated by independent clinical research. Four randomised controlled trials have shown consistent improvement in asthma medication adherence, ranging from 144% to 180% in children (Chan et al., 2015; Morton et al. 201X) and 33.3% to 58.7% in adults (Charles et al. 2007; Foster et al., 2014). Subsequently, the three studies measuring clinical outcome have demonstrated improved patient health as indicated by a reduction in oral corticosteroid use, reliever medication use, emergency room visits, lost school days and asthma morbidity score (Foster et al., 2014; Chan et al., 2015; Morton et al., 201X).
Audiovisual reminders markedly improve adherence to inhaled corticosteroids and thus increase health outcomes, whilst tracking reliever use may allow early detection of severe exacerbations (Patel et al., 2015). Furthermore, the objective nature of electronic adherence data enables an open and honest discussion about adherence and the barriers encountered by the patient. In turn, through HCP (or parental) intervention, this results in practical solutions to better manage asthma and or COPD.
The Smartinhaler™ platform was designed with patients in mind. In the development of the Smartinhaler, we’ve consulted patients and medical professionals to produce a user-centred system that facilitates good medical practice as well as empowering the patient.
For a list of references please visit our website: http://www.smartinhaler.com/outcomes/
 
 
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Long term conditions: a whole system, person-centred approach / Digital health / Innovation and adoption / Patient and medicines safety / Person centred care
Benefit to NHS:
Potential reduction in mortality, hospital admissions, hospitalisations and A&E visits: Asthma accounts for approximately 60,000 hospital admissions and 200,000 bed days a year, with many others visiting A&E clinics without stay, uncontrolled asthma places a significant burden on NHS (British Lung Foundation, 2016). Williams et al. (2004) suggest adherence to inhaled corticosteroids could reduce hospitalisation by 60%. Given Smartinhaler’s ability to significantly and consistently improve adherence, it is expected that implementation of Smartinhalers™ will reduce the burden on the health services and most importantly improve the quality of life for asthmatics.
Potential reduction in medication wastage: In the UK, more than £230 million worth of asthma medicines are returned to pharmacies every year with a significantly larger proportion thought to be disposed by the patients themselves (Horne, 2006). Smartinhalers™ may reduce this wastage by improving treatment adherence as well as facilitating an open discussion about treatment between the clinicians, parents and patients.
Currently, the only similar technology implemented by some NHS funded hospitals is Florence – a telehealth application that connects patient data to healthcare professionals and text messaging to encourage positive behavioural change in patients with chronic illnesses. Although medication reminders can be sent to the phone, it appears text message reminders are less effective than direct device reminders (such as those in the Smartinhaler™) (Strandbygaard et al. 2010; Petrie et al. 2012). Furthermore, objective data about medication adherence cannot be collected using Florence and thus does not allow data-based clinical decisions for asthma. To our knowledge, there is no similar or equivalent technology used in current NHS practice specific for asthma. Standard physician care, asthma action sheets and for children, parental care, is the extent to which asthma medication adherence is addressed by the NHS. The Smartinhaler™ device would work alongside the current systems, used as an additional tool to improve the health of asthmatics, seamlessly integrating with current NHS practice.  
 
Initial Review Rating
5.00 (1 ratings)
Benefit to WM population:
Asthma is a major health issue in West Midlands. West Midlands (and South East) had the highest mortality rate for asthma. Furthermore, West Midlands has one of the highest asthma-related hospital admissions in England; in 2008-12, West Midlands was considered one of the worst five regions of England for asthma related admissions; other regions included North East, North West, and Yorkshire and the Humber (British Lung Foundation, 2016). Asthma not only influences health, it is associated with significant cost to society including work and school absenteeism as well as loss of productivity while at work (Bahadori et al. 2009).  
Taken together, introducing innovative and cost-effective digital health solutions is pivotal to the improvement of the health of West Midland’s asthmatics in increasing the quality of life, reducing burden on health services, and increasing economic productivity. As such, the implementation of Smartinhalers™ is a step forward for West Midlands health care system to alleviate the burden of asthma. 
REFERENCES
Bahadori et al. (2009). Economic burden of asthma: a systematic review. BMC pulmonary medicine, 9(1), 1.
British Lung Foundation (2016). Retrieved from https://statistics.blf.org.uk/asthma
Current and planned activity: 
  • Expansion of clinical data: several large and small clinical trials using Smartinhalers in asthma and COPD are on-going or in the prepublication stage. We expect more clinical trial results to be published this year and in the years ahead.
  • Development of new devices and further improvement of existing devices
  • Further improve patient-centred design of the Smartinhaler’s user interface
  • Expansion of global regulatory approvals
What is the intellectual property status of your innovation?:

Adherium has various patent protection in numerous jurisdictions. Furthermore, we hold numerous trademarks and registered design rights for our Smartinhaler™ range.
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
1 year
Ease of scalability: 
3
Read more
Hide details
John Tarplee 05/07/2016 - 11:03 Publish 2 comments
5.5
2
Votes
-99999
Innovation 'Elevator Pitch':
Lilie EPR captures outpatient activity, diagnoses and treatments for GUM patients, provides the team shared access to patient records enabling instant communication between the service, lab and patient; reducing costs with efficient data management.
Overview of Innovation:
Leading the way  in the Management of Sexual Health Services
The modern day sexual health service challenges are significant. Public Health England (PHE) indicate that there were 446,253 sexually transmitted infections diagnosed in England in 2013 with Chlamydia being the most common, making up 47 per cent of all diagnosed cases. The most expensive cost to the NHS is HIV Infection, each new case of HIV infection is estimated to represent between £280,000 & £360,000 in lifetime treatment costs. Although the fall in teenage pregnancy is one of the success stories of the last decade in the public health field. However there is always room for improvement especially with more sexually active young people.
 
Lilie provides Sexual Health clinics and HIV services with a comprehensive Sexual Health computer software solution. Lilie is a fully scalable Electronic Patient Record system (EPR) used to capture outpatient activity, referrals, diagnoses and treatments for genitourinary medicine (GUM) patients. Having all the patients’ data in one EPR system provides all the clinic team members with fast access to patient data greatly reducing administration functions. All audit and quality measures are incorporated automatically reducing clinical risks and improving the quality of sexual health services.

Lilie’s core is the base application which is a totally secure full EPR system with comprehensive patient communication, statutory reporting i.e. HARS, SRHAD and GUMCAD, adhoc report generation. Additional modules to the core system can be purchased allowing the client to meet their budgetary requirements. Additional modules include: Contraceptive & Reproductive Health which is a secure and efficient way to manage Contraceptive and Reproductive Health data and services/ Chlamydia Screening providing exceptional NCSP data capture and reporting facilities/ Prescribing which includes the Dictionary of Medicines and Devices (DM+D)/ SMS Texting is an effective way to improve patient communications and reduce DNA rates/ Touchscreen allows the patient to announce their arrival in clinic and discretely enter personal data/ Internet Booking to empower your patients with time-saving, secure appointment management/ Lab Communications for fast and secure ways to order laboratory tests and receive results/ Collect for collecting patient data using mobile devices within an outreach environment.


For more information visit http://6pmsolutions.com/products/clinical/lilie
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Wealth creation / Clinical trials and evidence / Digital health / Innovation and adoption / Patient and medicines safety / Person centred care
Benefit to NHS:
Improves Productivity
Lilie is intuitive and easy to use allowing clinicians to spend more quality time with patients whilst allowing clinics to reduce appointment, management and reporting times. By default, the patients’ previous responses to questions are automatically populated hence saving clinic time and improving patient care.

Speeds up data collection.
The patient data you collect during your general working day is input into the electronic patient record (EPR) easily. The software and the dynamic screens change, validate and evolve as you enter this data.   

Reduces DNA’s
Lilie Online Internet Booking offers patients a discreet, more convenient and alternative route to treatment without staff intervention reduces management costs.  Lilie discrete SMS Text messaging will send out appointment reminders giving the patient the ability to confirm or cancel an appointment, freeing up slots for other patients.


Ensures clinical safety and maximises patient convenience.  
Lilie displays a patient banner across the top of the screen displaying key patient information, ensuring clinical safety whilst speeding up the clinic consultation.

Intuitive and easy to use. 
Lilie allows clinics to be more flexible according to their own services requirements. The consultation screens are easy to use and patient data can be easily collected. Lilie is so intuitive, you will reduce your training needs.

Ensures accurate recording of data. 
Data is input during the consultation whilst ensuring the right questions are asked at the right time, reducing and removing transcription errors. Thus written notes and illegible hand writing are a thing of the past.  

Accessible anywhere.
Lilie is available on a web based N3 platform and the cloud allowing access to different users over the Internet. This ensures improved availability, no costly client installations and access from any trust computer or device.

Simplified deployment, maintenance and painless upgrades.
The Lilie hosted solution can be deployed quickly and easily since no client terminal installation is required. Drastically reducing the initial investment in IT infrastructure.
The hosted solution ensures software updates and backups are carried out “behind the scenes”, reducing the costs associated with client installations and reducing the involvement of IT department resources.  This also means that when the number of users increase, no further investment in hardware, bandwidth or resources is required.
 
Initial Review Rating
4.20 (1 ratings)
Benefit to WM population:
The Best outcomes for people and for populations depend on effective collaboration and cooperation. We can get there faster with Lilie’s integrated working tools.

Nationally, around four million people per year use NHS contraception services. The number of visits to genito-urinary medicine (GUM) clinics has doubled over the last decade and now stands at over a million a year.  The economic climate and pressure on resources are encouraging everyone to explore new approaches and opportunities that can deliver better outcomes and better value. The fields of sexual health, sexually transmitted infection (STI), contraception, reproductive health and HIV are frequently talked about as a whole service, yet each is separate and has its own defining features. Different elements have different commissioning arrangements which add to the complexity.

Lilie EPR for sexual health has been designed specifically to support multi-disciplinary teams treating sexual health and HIV. This “whole system” approach makes sense to the service user, the community and the commissioner. Having patient data in an EPR system provides all clinic team members with fast access to patient records, greatly reducing administration functions. Unlike paper records, patient data can be accessed from any Trusts computer enabling more than one healthcare professional to access the same record at the same time.  Patients’ needs for integrated pathways are at the heart of the case for whole system commissioning. Poorly connected care increases the risk of service users falling out of the system which can reduce their treatment adherence and worsen subsequent health outcomes. Disjointed pathways also result in missed opportunities to address people’s wider needs.

‘Lilie is a complete comprehensive software system that manages; Sexual Health, Contraceptive, HIV and Reproductive Health services.  There is also a separate module for contraception, so as to provide ‘Services’ with a choice of modules depending on their requirements.’

Greater adoption of this technology would also allow our company to develop additional modules for this system, as well as expand our team here in the region.

Lilie is the market leading Sexual health software in the UK
Current and planned activity: 
Lilie is constantly being evaluated to ensure it meets the demands of the users.  The software roadmap is ever evolving and this is helped by the Lilie User groups where nearly 200 users attend annually.

A new version of Lilie is being released where dynamic forms will feature heavily.  For more information contact lilie@6pmplc.com.



Planned / required activity 
  • Procurement / Adoption: -  We would like to see greater regional adoption of our Lilie and integrated suites of products and modules
  • Trials - We are interested in discussing opportunities with Trusts for additional trials, evaluation and validation of our system 
What is the intellectual property status of your innovation?:
Lilie is owned by 6pm Group.
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
1 year
Ease of scalability: 
2
Read more
Hide details
Joanne Shrimpton 16/06/2016 - 14:34 Publish Login or Register to post comments
0
0
Votes
-99999
Innovation 'Elevator Pitch':
The On Call Room is a social network for medical professional providing a platform to connect the best  medical/healthcare minds from around the world so they can share, learn and collaborate; progressing medicine.
Overview of Innovation:
The On Call Room is the free social network for healthcare professionals. Readily available on Google Play and the App Store, The On Call Room has registered users from 11 different countries around the world. With users using the platform to educate, inform and collaborate with one another, The On Call Room is a growing global community of healthcare professionals. From doctors - nurses, medical students - “Pre-reg” pharmacists, anaesthesiologists - geriatricians The On Call Room is a place to bring all these specialists together.
Being ISO27001 and HIPAA compliant, The On Call Room provides a safe, secure environment outside of commercial networks such as Facebook and Linkedin in which medical professionals can collaborate. Designed by medical professionals for medical professionals, The On Call Room has tools in place to facilitate the privacy and confidentiality of both medical professionals and patients, without stifling the progression of research or medical education.
The On Call Room is here to facilitate the already growing use of digital tool in healthcare, providing a reduced risk environment where healthcare professionals can share medical learning and innovations with other professionals not just in the user’s locality but also the world.
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Education, training and future workforce / Digital health / Innovation and adoption / Patient and medicines safety
Benefit to NHS:
The On Call Room is a mobile application free at the point of use; with no implementation fees or sign up fees to any healthcare organisation.
The benefits The On Call Room has for the NHS is in the value of knowledge transfer. With the shortage of medical professionals in the UK* and many experienced staff soon retiring, we must ensure our current practising and the new up and coming healthcare practitioners are provided with every opportunity and resource to learn from the best medical minds from around the world and The On Call Room is a means of facilitating this.
Building on an already rigorous rigmarole of training required to be a healthcare professional, The On Call Room is a place to make knowledge relevant and plug any knowledge gaps an individual may have as our active community aids and assists each other to create an open repository of collaborative knowledge.
As we continue to grow our community both nationally and internationally The On Call Room will be a vibrant environment where a proven transformative practice can be shared and adopted at scale. An example of this is The Royal Free Hospital’s, Dr Sam Hare’s Heimlich valve management of iatrogenic pneumothorax, which has been shared on our platform and viewed by our  users around the world, sharing a new method to reduce hospital stay in patients after lung biopsies.
Being a digital innovation The On Call Room removes physical knowledge boundaries, such as locality and provides all thoses who sign up access to see the best innovations our community has to offer, providing them with a platform in which they can embetter themselves as professionals if they so choose.
*UK Government Shortage Occupation list, pages: 6, 7 and 13. See supplement documents
Initial Review Rating
1.80 (2 ratings)
Benefit to WM population:
With three medical schools in the West Midlands region, The University of Birmingham, The University of Warwick and Keele University, and a renown teaching hospital, Queen Elizabeth Hospital Birmingham, The On Call Room could be a prime educational resource to connect all those in training to the wider medical world, providing them with even more exposure in addition to their placement years.
For the wider population of the West Midlands, The On Call Room is here to facilitate the embetterment of healthcare professionals and the more they know the more adept they can be in their jobs, benefitting the wider community as a whole.
Current and planned activity: 
Internationally the team is currently onboarding healthcare professionals from India and all the healthare professionals from the country of Nepal.
In the UK we are in communication with Addenbrooke’s, a Cambridge University Hospital to onboard them to The On Call Room and other applications.
After engaging Milton Keynes University Hospital, London South Bank University and The University of Buckingham Medical School in our beta and now onboarding various Medical Societies across the country such as King’s College London MedTech Society our plan is to engage with as many healthcare professionals as we can across the country.
Support Requirements:
Helping ensure we are NHS Information Governance compliant to add to our ISO27001 and HIPAA compliance certifications.
What is the intellectual property status of your innovation?:
Medic Creations, The On Call Room's parent company are the sole owners of the On Call Room's intellectual property.
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
6-12 mon
Ease of scalability: 
Simple
Read more
Hide details
Akil Benjamin 09/06/2016 - 18:10 Publish 1 comment
4
1
Votes
-99999
Innovation 'Elevator Pitch':
We have a fully developed managed service ready to provide connectivity to mobile screening vans; automatically wirelessly transfer images to hospital PACS; remove outdated paper based processes and transform the metrics of breast screening.
Overview of Innovation:
For 25 years mobile breast screening vans have operated in isolation from Hospital HQs. Every day hard drives full of patient images are transported by taxi, courier, or most commonly fully trained radiographers between the van and hospital. Appointment lists are closed well in advance to allow them to be physically transported to the van and they are therefore outdated by the time they arrive. Clinical and administrative notes are made on paper which is also physically transported before the notes are transcribed into application software. Targeted turnaround time between screening and result has been 14 days for over 25 years.

​Our managed service revolutionises this process and can reduce the steps involved from 42 to 21.

​We transmit images directly from the van to hospital PACS in as little as three minutes. We make appointment systems live on the van and synchronise them with HQ. We create access to clinical applications so that all notes can be entered directly at point of need. We provide on board access to email, internet and intranet which has never been provided before.

​We give the HQ real time visibility to the van enabling them for the first time ever to see that staff have arrived safely and that screening has commenced on time. Our service can transform the metrics of screening and open the doors to radical overhaul of efficiencies and turn around times for results. We can remove all paper based systems and transform the reading and reporting process.

​All of these things can be achieved to deliver a better working environment, more efficiency, greater flexibility, better data accuracy and much improved data security and could normally be funded by cost savings that the service itself will generate.

We need help to accelerate the pace of adoption.
Stage of Development:
Close to market - Prototype near completion and final form may require additional validation/evaluation and all CE marking and regulatory requirements are in place
WMAHSN priorities and themes addressed: 
Wellness and prevention of illness / Digital health / Innovation and adoption
Benefit to NHS:
  • Improved throughput on existing capital equipment
  • More flexible service at point of need
  • Improved accuracy by removing transcription errors
  • Better working conditions for radiology staff
  • Reduced risk of data loss
  • Improved management information
  • Better work processes
  • Removal of paper based processes
  • Opportunity to reduce the anxious waiting period between screening and results
Initial Review Rating
3.40 (1 ratings)
Benefit to WM population:
The Breast Screening Programme (BSP) is one of the largest and most important screeniong programmes in the UK. The benefits of regular screening, early detection, and faster treatment are well proven and documented. Our service enables operators of the programme to bring their service into the 21st Century. The benefits shown above are extensive and far reaching and would impact directly in the service provided to the women of the West Midlands who would find the service more flexible, more accurate and more secure.
Current and planned activity: 
Two mobile vans operated by UHB are already contracted to our service. We now need to expand to the other operators in the West Midlands. We have a fully developed demonstration trailer that we can bring to any site. It would be great to have a fully documented case study on our service anda way into becoming an appproved supplier to the NHS. We need help.
What is the intellectual property status of your innovation?:
We need to investigate the potential for IP in our software.
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
1 year
Ease of scalability: 
Simple
Read more
Hide details
David Osmond 01/06/2016 - 18:08 Publish 1 comment
0
0
Votes
-99999
Innovation 'Elevator Pitch':

Using simple technology, we enable care homes to coordinate the monitoring of vital signs, weight and hydration acting as an early warning system with direct integration into GP systems.

Overview of Innovation:

Inhealthcare have developed a Digital Care Home service, which coordinates the monitoring of vital signs, weight and hydration. It acts as an early warning system, highlighting changes in health which may otherwise go undetected. Their service includes a digital patient record which integrates directly with GP systems, meaning that it can be accessed by local NHS teams.

Our digital health services are in place in over 80 care homes in the UK, helping care home managers and nurses carry out frequent checks on residents.

Find out how it works on our website http://www.inhealthcare.co.uk/digital-health-solutions/care-homes/.

You can also read a blog from Georgia Nelson about a pilot of our Digital Care Home in 14 care homes in Northern Irealand http://www.inhealthcare.co.uk/telehealth-undernutrition-service-care-homes-northern-ireland/.

Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Wealth creation / Clinical trials and evidence / Digital health / Innovation and adoption / Patient and medicines safety / Person centred care
Benefit to NHS:
  1. Reduces non-elective admissions through detecting deteriorating health early on
  2. Improves co-ordination between the NHS and the care home through better sharing of information with GP system integration
  3. Supports early hospital discharge by giving clinicians more confidence that needs will be met in the care home
  4. Improves the visibility of residents’ health, meaning community nurses can better monitor patients without the need for travel
  5. Improves compliance around care
Initial Review Rating
5.00 (1 ratings)
Benefit to WM population:

1. Enhanced monitoring of residents, enabling early detection of health deterioration enabling timely intervention.

Current and planned activity: 

Our digital health services are in place in over 80 care homes in the UK, helping care home managers and nurses carry out frequent checks on residents.
 

Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
N/A
Ease of scalability: 
Simple
Read more
Hide details
Lauren Ramsey 24/05/2016 - 13:41 Publish Login or Register to post comments
3
1
Votes
-99999
Innovation 'Elevator Pitch':
We have developed a clinically led digital health solution for warfarin patients at risk of stroke. Our technology enables patients to self-test from their own homes with remote clinical support, communicating their INR in a way that suits them.
Overview of Innovation:
Our INR self-testing service has been rolled out to 5,000 patients, making it one of the largest in Europe. Across the UK, patients on the service are remotely monitoring their INR away from the clinic using a Roche CoaguChek® device. Readings are sent to their nurse via an automated phone call or by logging onto an online portal. Readings automatically go through anticoagulation software where the next dose is determined. A clinician approves the next dose and the patient receives a second form of communication, either an automated phone call or an email informing them of their next warfarin dose and date and time of next test. Find out more here http://www.inhealthcare.co.uk/product/inr-self-testing/.
Our self-testing study concluded patient’s therapeutic range (TTR) improved by 20% for 70% of patients. In comparison a controlled cohort of clinic based patients had seen only 49% of their cohort improve by an average of 2%.This improved TTR predicts to save 400-500 strokes per year.” – Ian Briggs, Associate Director of Business Development, County Durham and Darlington Foundation Trust.

To find out more about INR self-testing in County Durham and Darlington Foundation Trust download our case study here http://www.inhealthcare.co.uk/resource/county-durham-and-darlington-nhs-foundation-trust/.

The service has also been rolled out in Wigan, Ilkley and the Isle of Wight. Read this blog from our CEO Bryn Sage about INR self-testing in the Isle of Wight http://www.inhealthcare.co.uk/isle-of-wight-are-leading-the-way-with-inr-self-testing-for-warfarin-patients/.

Outcomes:
  1. Improved patient outcomes: In a recent 24 month follow up study from County Durham and Darlington Foundation Trust we found over 70% of those on the service improved their time in therapeutic range by 20%.
  2. Improved patient satisfaction: The service is quick and easy to use. Patients do not have to take time out of their day to attend appointments and aren't bound to NHS opening hours. 100% of those surveyed said they'd recommend the service to others.
  3. Increased efficiency: Enabling patients to self-test enables resources to be distributed elsewhere.

 
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Digital health / Innovation and adoption / Patient and medicines safety / Person centred care
Benefit to NHS:
  • Reduced workload
  • Increased capacity
  • Cost savings
  • Able to spend more quality time with patients that need to attend the clinic
  • Access to real time patient data
  • Able to identify any adversities and make changes in treatment much sooner
  • Able to make informed decisions around patient care
  • Choice of communication method to suit their patients
Initial Review Rating
5.00 (3 ratings)
Benefit to WM population:
  • More flexibility for patients
  • Improve clinical outcomes
  • Not bound to NHS opening hours
  • Able to find out more around condition
  • Less clinic visits and associated costs
  • Technology is quick and easy to use
  • Clinicians have access to a continuum of data meaning patients don’t have to repeat themselves during appointments
Current and planned activity: 
We are currently working with a number of NHS organisations that have implemented our INR self-testing service including County Durham and Darlington NHS Foundation Trust, Wigan Borough Federated Healthcare, Isle of Wight CCG, Ilkley Moor GP practices.
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
N/A
Ease of scalability: 
Simple
Read more
Hide details
Lauren Ramsey 24/05/2016 - 13:20 Publish Login or Register to post comments
5
1
Votes
-99999
Innovation 'Elevator Pitch':
Do you wan to improve outcomes and gather PROMs in MSK or Pain Management:

Improving Outcome and Making Saving of 15 % admitted care costs
Digital Assessments for PROMS
Self Assessment / Management of Chonic Pain.
​12 Tools for Self Management
CBT
Overview of Innovation:
https://www.youtube.com/watch?v=r_qVLCmv4JM

​PainSense ( www.pain-sense.co.uk) is two digital apps, designed to give more support for self-management for people living with persistent pain. The resources include an app version of the "Pain Toolkit" developed by Dr Frances Cole and Pete Moore, and an app version of the "Pain Management Plan" developed by Dr Cole and Professor Bob Lewin, as well as a set of app-based needs assessment and patient-reported outcome tools, and eLearning resources for clinicians. The apps can be integrated into clinical systems such as SystmOne and EMIS or accessed on a secure portal.
 
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Mental Health: recovery, crisis and prevention / Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Education, training and future workforce / Digital health / Innovation and adoption / Person centred care
Benefit to NHS:
Health Economics – Leeds ( July 2016 )
•Increase in the number of patients entering the pathway in the 11months for which we have comparable data – exact numbers to be confirmed.
•Annualised saving in total cost of pathway of c£280,000 representing a 9% reduction in total pathway spend of £2.9million
•Switch from 58% of 1st OPs being seen in acute trusts, to 29%, representing substantial transfer of care to community sector. This trend is expected to continue still further
•Reduction in hospital in patient and day case procedures of 6% with an associated cost reduction of 15%, indicating fewer and lower complexity medical pain interventions
•Substantial improvement in patient reported outcomes. Sample patient reported data from 216 discharged patients from our key community provider has demonstrated an average 27.5% reduction in the level and extent of their pain (using DOLO scoring) and a 34% improvement in their confidence and ability to cope with their pain (Using PSEQ). On their Friends and Family test outcomes, of 119 patients 66% responded that they would be extremely likely, and a further 29% likely to recommend the service to their friends and family - an overall positive response of 95%.
We have previous figures re Opioid reduction in pilot sites.
Initial Review Rating
3.20 (2 ratings)
Benefit to WM population:
Improving Self Care - Self Managment Skills
Improving Health Function - Data form FrCole.


 
Current and planned activity: 
We are keen to roll out the PainSense Service across the UK, we have already engaged with several CCG but are keen to work with other from as early as pre tender and or service redesign stage.

SWBH is already using PainSense in the West Midlands and we are keen for more sites so please do get in touch.
 
What is the intellectual property status of your innovation?:
IP is with ADI, PainToolKit and PMP, registered.
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
0-6 mon
Ease of scalability: 
Simple
Read more
Hide details
Keli Shipley 11/05/2016 - 18:21 Publish Login or Register to post comments
0
0
Votes
-99999
Innovation 'Elevator Pitch':
Optifit is the first clinically validated therapeutic bra and fitting system, promoting a balanced posture, reducing musculoskeletal health problems associated with larger bust sizes. Optifit provides a proven alternative to breast reduction surgery
Overview of Innovation:
The OptiFit bra and measurement system, designed by a Consultant Plastic & Reconstructive surgeon with bespoke manufacturing in the UK. www.optifitbra.com
  • Ensures an effective and comfortable ‘bespoke’ fit
  • Significantly reduces trauma and pain in Thoracic and Lumbosacral regions
  • Prevents overstretching of the suspensory ligament reducing the chance of stretch marks.
  • Preserves body shape
  • Maintains healthy posture, relieving pressure on diaphragm and balance pelvis
  • Reduces risks of tissue maceration, intertrigo and fungal growth
It is estimated that 70% of women wear the wrong size bra. The traditional alphabet bra size measurement system was initially only established for cup sizes A-D, but with 40% of British females measuring a D cup or above the same level of fit and support is not achieved in larger sizes. Failure to support the breasts can lead to many physiological conditions including back and breast pain.
 
Inappropriately sized and positioned back straps cause existing bras to slide away from the breasts reducing support. It is estimated that 70% of women wear poorly fitting bras and that 99% of women with large breasts wear the wrong size bra.  Professionally fitted bras are often as poorly fitted as ‘off the shelf products.
 
Bras that do not support the breast correctly cause many skin problems. If the weight of the breasts is mostly supported by the shoulder straps, these can dig in and cause angry red welts to develop.
Underwired bras push into the tissue leading to lesions, marks and sores.
Optifit bras do not use underwires. They hold the breast in its natural position away from the body preventing the above problems.
If the breasts are not supported away from the ribs, rubbed skin, maceration, intertrigo and fungal infections can develop underneath.
 
what_is-1.png     what_is-2.png     
 
Summary of interim research study findings -
  • Can help patients with Back pain
  • Can obviate need for breast reduction surgery in many patients
  • Is a cure for Inframammary intertrigo
Can potentially help patients with mastalgia especially those with associated shoulder girdle dysfunction
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Education, training and future workforce / Wealth creation / Clinical trials and evidence / Innovation and adoption / Person centred care
Benefit to NHS:
How best to allocate surgical resources and time within the NHS is a problem with which we wrestle and disagree constantly. Reduction mammaplasty is surgery rationed in NHS practice, yet evidence suggests that those who undergo it derive significant improvements in physical health and quality of life.
 
NHS recommends professionally fitted bras prior to Breast reduction surgery but has not evaluated their efficacy.
 
Many women do not fulfill the criteria for surgery e.g. high BMI.  Such patients have nowhere to go and are a burden on the NHS, requiring drugs for back pain, intertrigo etc. Furthermore, women with high BMI’s cannot find a properly fitted bra. The Optifit bra will help such patients and overall reduce the need for breast reduction surgery. Women seeking reduction mammaplasty often wear ill-fitting bras and are therefore likely to exacerbate some of their presenting symptoms as a result. Women may wait years from referral to surgery and symptom relief. A correctly fitted bra alleviates symptoms and may even remove the need or wish for surgery.

Savings from reduced surgical intervention and associated consultations, imaging and follow ups will be enormous, (‘21,328 procedures were carried out between 2006 and 2011, some on girls as young as 15 -which, at £5,000 each, cost taxpayers more than £106 million’. (Daily Mail July 2014)).
 
Back Pain: OptiFit should be a 1st line treatment for LBP in women with high BMI’s and/or large breasts.  A systematic review on global prevalence of LBP the highest prevalence showed women aged between 40-80 (incidence 11.9%  http://www.ncbi.nlm.nih.gov/pubmed/22231424). The OptiFit intervention would help many patients and demonstrate significant savings for the NHS
 
Intertrigo: A direct result of friction between two skin surfaces. With poorly fitted bras there is a mismatch between cup/cradle diameter and breast base.  Patients I see regularly in my clinic have had several ‘Professional’ fittings and still cannot find the correct size bra. With it’s unique design the Optifit bra remains in the inframammary crease (however large the breast and BMI may be) and it is therefore impossible to get intertrigo
 
Mastalgia: Incidence of mastalgia in the general population is reported as over 60% http://www.ncbi.nlm.nih.gov/pubmed/9240595  Most women who attend Breast Clinics with breast pain also have musculoskeletal pain related to breast size.  The 1st line of treatment for mastalgia is a professionally fitted bra
Initial Review Rating
2.60 (1 ratings)
Benefit to WM population:
The savings resulting from reduced surgical intervention and the associated consultations, imaging and follow up will be enormous, (‘21,328 procedures were carried out between 2006 and 2011, some on girls as young as 15 - which, at £5,000 each, cost taxpayers more than £106 million’. (Daily Mail July 2014)). In addition the benefits in QALY outcome measures for women will also be substantial.
 
Back Pain: We feel that this product should be recommended as a first line treatment for low back pain in women with high BMI’s and/or large breasts.  In a systematic review on the global prevalence of the low back pain in the world the highest prevalence was noted to be in women between the age of 40-80.  The incidence was found to be 11.9%  http://www.ncbi.nlm.nih.gov/pubmed/22231424 .. This simple intervention should help many patient and save the NHS on many interventions.
 
Inframammary Intertrigo:It is difficult to comment on the incidence of inframmary intertrigo in the general population as there is not ICD-10 or ICPC score.   Intertrigo is a direct result of friction between two skin surfaces.  This is due to a poorly fitted bra as there is a mismatch between the cup/cradle diameter and the breast base ( the breast base in patients with high BMIs can be several centimetres more than the cup/cradle diameter in professionally fitted bras).  The patients I see regularly in my clinic with intertrigo have had several fittings and still cannot find the correct size bra as it simply does not exist for them. With its’ unique design the optifit bra, however, stays at the inframammary crease( however large the breast and BMI may be) and it is simply not possible to get intertrigo.
 
Mastalgia: The incidence of mastalgia in the general population has been noted in studies to be over 60%.  http://www.ncbi.nlm.nih.gov/pubmed/9240595 .   Most women who attend Breast Clinics with breast pain also have musculoskeletal pain related to breast size.  The first line of treatment for mastalgia is a professionally fitted bra.
Current and planned activity: 
Ongoing research studies at University of Central Lancashire:
  • Exploring the OptiFit bra solution against fashion industry standards
  •  To determine the initial and short term biomechanical effects on posture when wearing the OptiFit bra compared to the standard or usual bra, in individuals with back or neck pain.
  • To determine the initial and short term effects on breast health, pain, activity and comfort when wearing the OptiFit bra compared to the standard or usual bra, in individuals with back or neck pain 
Required studies:
  • A community based study of incidence of inframammary intertrigo in general population resulting from poor bra fitting
  • A comparative efficacy study is required for surgical and non surgical management of symptomatic macromastia
  • Health Economics cost benefits analysis of surgical vs non surgical intervention
Further trial partners required to evaluate the product and measurement system
What is the intellectual property status of your innovation?:
Patent for Bra (GB2362560B): The granted patent has four independent claims. These are (claim 1) which covers the bra itself,  (claim 7) which covers a method of fitting a bra according to the invention, (claim 10) which covers a range of bras according to your invention and (claims 11 and 12) which cover a bra and method of making a bra respectively with particular emphasis on the back portions.
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
0-6 mon
Ease of scalability: 
Simple
Read more
Hide details
Atul Khanna 29/04/2016 - 11:18 Publish 2 comments
5.7
3
Votes
-99999
Innovation 'Elevator Pitch':
ExerSciz Solutions is an on-line tool that creates individualised exercise programs for risk reduction, disease treatment and overall improved health for patients with Long Term Conditions.
Overview of Innovation:
ExerSciz Solutions utilises the latest in exercise and scientific literature to develop programs that are specific to an individual’s physiology, health condition and goals, level of exercise, time available and individual choice of cardiovascular training.
Patients, supported by clinicians, can select from a number of goals. These include weight loss, with or without calorie restriction, risk reduction and treatment of heart disease and stroke, diabetes, metabolic syndrome, arthritis, osteoporosis, balanced health and many other health based goals.
The programs adapt to the availability of various exercise equipment. Programs can be designed for those without any equipment. The programs can be done at home, in the gym, or wherever an individual chooses. The programs will progress week to week and month to month as long as an individual is doing approximately 70% of his or her workouts. The cardiovascular portion of the program gives clients their specific exercise zones to work out in. The exercise zones are unique to each individual's particular health needs as well as body physiology.  By using both screening tools and perceived exertion, the programs are safer than a patient choosing to exercise on his or her own. Since most individuals have smart phones today, an ExerSciz program is just like having a personal exercise trainer in the client's pocket at all times.
Patients are able to perform an assessment using their smart phone in order to give them an ExerSciz Fitness index ("EFI") rating.  The EFI is a proprietary exercise score that compares each client to age adjusted norms and allows each client to benchmark their current status, as well as monitor progress. In addition, patients are able to track their activity on the website, giving them both activity scores and health scores.  We will soon have the ability to automatically track this if the client is using a wearable device that is compatible with the ExerSciz program.
Patients and doctors will be able to see the results and appreciate that they are “Exercising smarter, not harder” as their program is literally putting exercise based science into their unique personalised exercise experience, promoting their health and wellbeing. 
An individualised ExerSciz program will be complementary to any ongoing health or medical intervention, initiative and treatment a patient may be involved in and should reduce health costs, as well as help develop ownership of their own health.
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Education, training and future workforce / Wealth creation / Clinical trials and evidence / Digital health / Innovation and adoption / Patient and medicines safety / Person centred care
Benefit to NHS:
  • Cost saving benefits as a result of better disease prevention, health promotion, disease treatment, rehabilitation and ongoing maintenance of health and function.
  • Time spent in physiotherapy and follow up appointments is better spent, as exercise can also  be conducted safely in an unsupervised manner and/or at home
  • Clinicians can monitor the progress of patients who exercise, resulting in the formulation of enhanced treatment plans.
  • ExerSciz Programs aid in the development of the patient’s ownership and control of his or her own health objectives.
  • ExerSciz can help to maintain an individual’s health, prevent the deterioration of disease, allow convenient and cost effective access to exercise expertise and can help to educate patients about the best exercise for their condition.
Initial Review Rating
5.00 (1 ratings)
Benefit to WM population:
ExerSciz Solutions directly fits into the Digital health innovations campaign and could also assist with the diabetes campaign. Our app can help to maintain an individual’s health, prevent the deterioration of disease, allow convenient and cost effective access to exercise expertise and can help to education patients about the best exercise for their condition. Ultimately saving the NHS within the region money and avoidable admissions.
In addition the benefit ExerSciz Solutions can have on multiple long term conditions would directly benefit the West Midlands region.  
The most common reason individuals give for starting an exercise program is to lose weight, however most individuals, do not know where to start, are afraid they may hurt themselves and for a variety of reasons, will not join a gym. Many individuals, wanting to lose weight, often exercise too hard, in a zone that is less effective for weight loss and more prone to injury. These individuals frequently do not lose weight, often get frustrated and stop exercising.  Access to this tool, as part of a larger health campaign, will give individuals enough trust in the site to at least initiate and try a program. The ExerSciz application will enable an individual to exercise with or without calorie restriction in a safe and effective manner, using exercise zones that are specific to body fat loss, as well as an included nutritional recommendation tool to complement this.
Exercise has been shown repeatedly in scientific studies to have significant overall health benefits as well as increased productivity and enjoyment of life. Even a small percentage change in non-exercisers to exercise adopters could have significant socio/health-economic benefits to the region.
Current and planned activity: 
Current activity:
Digital Health Solutions is actively seeking NHS partnerships to engage with ExerSciz Solutions. The app has been developed and evaluated within Canada and USA and a collaboration within the UK is currently being sought as the product is successfully being marketed and used with Canada and the US.

Planned activity:
  • Procurement / Adoption of ExerSciz Solutions by West Midlands NHS Trusts
  • Evaluation of the app and its potential wide scale usage across the region and the wider NHS
  • Support with Information Governance, N3 connectivity and data capture to aid further growth and development within the NHS
What is the intellectual property status of your innovation?:
All intellectual property is owned by ExerSciz Solutions Inc. in US and Digital Health Solutions Ltd in the UK and Europe
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
1 year
Ease of scalability: 
Simple
Read more
Hide details
Andrew Lane 27/04/2016 - 16:21 Publish Login or Register to post comments
0
0
Votes
-99999
Innovation 'Elevator Pitch':
e-ASPECTS automates medical imaging analysis, providing confident decisions in the treatment pathway for acute stroke patients.  e-ASPECTS automatically implements the clinical scoring methodology, Alberta Stroke Programme Early CT.
Overview of Innovation:
Brainomix’s ground-breaking technology, e-ASPECTS, circumnavigates the time lag to treatment by automatically implementing the Alberta Stroke Programme Early CT Score (ASPECTS) scoring system on brain images from acute ischemic stroke patients, to identify and quantify signs of early ischemic stroke damage and provide an assessment to support treatment decisions.

Innovation of Brainomix e-ASPECTS Stroke Imaging
The key thing to note that is that the solution is highly innovative and first to market of its kind with no comparable solution available. Our co-founders include Professor Alastair Buchan, dean of medicine at Oxford University and the inventor of the ASPECTS score, and practicing clinician Professor Iris Grunwald, interventional Neuroradiologist at Southend Hospital and one of the first physicians to be successfully performing thrombectomies in the UK. 
  • e-ASPECTS is a decision support tool that automates the clinically validates ASPECT method scoring of CT scans, providing a fast, standardized result
  • e-ASPECTS is the only decision support tool for scoring non-contrast CT scans of stroke patients using the ASPECT method - a well established stroke scoring system
  • It is CE marked and has been validated to perform as well as expert Neuroradiologists in performing ASPECTS on hyper-acute stroke patient scans
  • Multiple randomized multicentre clinical trials have demonstrated (as recently as last year) that endovascular treatment is effective, and it is set to become the future standard of stroke care (in conjunction with existing thrombolysis treatments).
  • International guidelines for the selection of patients for this treatment include the ASPECTS score for identifying ischaemic core on non-contrast CT scans
 Health Economics
·         Reduced length of stay – baseline 0.04 days per patient
·         Identifies the correct treatment option for stroke patients and speeds up
          treatment times
·         Reduced decision making time for stroke patient – baseline 15 minutes per
          patient
·         Increased uptake of thrombectomy - baseline x 1.1 (i.e. 10% increase)
·         Cost savings - projected cost saving for a 15 minute time reduction in
          decision making is £40 of consultant time, plus £21 from reduced length of
          stay, leading to a total of £61 saving per patient. If thrombolysis uptake is               also increased by 20%, the total saving rises to £150 per patient.


 
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Advanced diagnostics, genomics and precision medicine / Digital health
Benefit to NHS:
Health Economics
·         Reduced length of stay – baseline 0.04 days per patient
·         Identifies the correct treatment option for stroke patients and speeds up treatment times
·         Reduced decision making time for stroke patient – baseline 15 minutes per patient
·         Increased uptake of thrombectomy - baseline x 1.1 (i.e. 10% increase)
·         Cost savings - projected cost saving for a 15 minute time reduction in decision making is £40 of consultant time,
          plus £21 from reduced length of stay, leading to a total of £61 saving per patient. If thrombolysis uptake is also
          increased by 20%, the total saving rises to £150 per patient.
Initial Review Rating
5.00 (1 ratings)
Benefit to WM population:
Better patient outcomes and treatment options.
Current and planned activity: 
We already have a number of NHS Hospitals and hospitals abroad using this solution. Once we have engaged with a Clinician who is interested in this solution we arrange to provide them with a demonstration so they understand the full benefits of the technology.
What is the intellectual property status of your innovation?:
IP is wholly owned by Brainomix. We follow a "trade secret" approach rather than patenting as we believe that this is more appropriate as it is a software device.
 
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
1 year
Ease of scalability: 
Simple
Regulatory Approvals:
Please describe any current regulatory approvals you have achieved and how they were met/ in progress/planned.
Commercial information:
Please describe how the product/service is being developed commercially, whether in development, trials, pilot or full commercial delivery. Include the results you have from any market/demand surveys and forecasts . Please include any research you have on the broader commercial opportunity for the innovation both within the health sector nationally and internationally.
Investment activity:
Please describe what stage of investment you have reached and whether you are seeking additional rounds of investment. Please include cash investment as well as investment of soft assets such as access to specialist equipment, knowledge, trial base etc. and indicate the types/sources of your investment such as grants etc.
Regional Scalability:
Please describe how the innovation could be scaled across the WM region. Have you implemented at scale in any other regions?
Measures:
What outcomes are you hoping to achieve and what are the measures that you will use to gauge the success of the innovation and how will these assessments be made? Please ensure that you have quality, safety, cost and people measures.
Adoption target:
What are the targets for adoption across the WM and what are the minimum viability levels?
Investment sought:
What investment are you looking for in order to support wider adoption of this innovation and what have you managed to secure to date? Please provide a breakdown of these costs if possible.
Read more
Hide details
Deb Whitehall 26/04/2016 - 17:26 Publish Login or Register to post comments
6
1
Votes
-99999
Innovation 'Elevator Pitch':
The Amplitude pro enterprise™ uses simple technology to allow clinicians & healthcare professionals to collect clinical outcomes and use them to measure a reduction in patient symptoms and an improvement in quality of life.
Overview of Innovation:
The Amplitude pro™ series is a new way of capturing and managing PROMS. 

All hospitals strive to continuously improve levels of patient care. In order to monitor the services you provide to your patients, you must measure what you do and how you do it. pro enterprise™ combines clinical outcomes and patient experience evaluations by utilising efficient, cost effective, web based software. The resulting information gives you an accurate insight into the performance of your hospital and the knowledge required to devise strategies to achieve continuous improvement.
The pro enterprise™ software is a simple, tailored online platform centred around two crucial elements, helping you to achieve a more personalised way of patient monitoring:
  • A user-friendly electronic patient portal which gives patients the freedom of completing their scores online at home, on site and via various hardware.
  • A consultant dashboard that gives your clinicians the ability to input patient specific complexity factors and procedure data quickly and easily.
The result is representative, accurate and meaningful data that paints a clearer picture of each patient’s level of health and expected recovery. Your clinicians are engaged with clinical outcomes processes at your hospital, you get the insight you need to better manage your hospital services and patients get a consistently high standard level of care.
pro enterprise™ is the first product to give an accurate, ‘whole picture’ view of your hospital’s performance. It is simple, cost effective and delivers precise and accurate data, selecting scores that are identified as important to you.
The data you collect in pro enterprise™ will allow you to monitor your service delivery, identify quality issues and demonstrate levels of care. Your hospital can be confidently transparent about its activities, resulting in reassurance to your community that you are offering the best care possible.
pro enterprise™ is available across all specialties and can be customised according to the needs of you and your clinicians. The system is quick, user friendly and mostly automated. By sending out the appropriate scores at pre-defined intervals, it seeks patient interaction electronically and automatically prompts patients to respond at key stages along the clinical pathway. Clinical information can be added using time saving custom defaults whereby the clinician can add data and the data collected is relevant and clinically validated.
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Digital health / Innovation and adoption
Benefit to NHS:
pro enterprise™ will interface with other hospital systems to capture demographic data, avoiding duplication and achieving staff acceptance and compliance. It can also run independently if that is your preference. pro enterprise™ abides by strict NHS Information Governance guidelines, Data Protection policies and has been penetration tested. Amplitude can host your system on its secure N3 server or you can choose to host the system internally. Amplitude offers additional services and guidance around patient engagement and communications to ensure that you have all of the skills and tools that you need to create a highly compliant, positive outcomes culture in your hospital.
Initial Review Rating
3.40 (1 ratings)
Benefit to WM population:
A coherent reporting system can be achieved by utilising Amplitude across the West Midlands Trusts. The reporting system would allow for a joined up report displaying results across individual hospitals and trusts, as well as over the region as a whole. The ease at which the results can be obtained and displayed should increase the engagement of both patients and clinicians across the West Midlands area.
Our innovation does not only benefit people of the West Midlands, but worldwide.
All information is supplied by patients and validated by clinicians, ensuring it is meaningful and representative and provides a rich picture of your individual healthcare experience.
Amplitude Clinical Outcomes is accredited by the Private Healthcare Information Network (PHIN) to collect outcomes data for the UK private healthcare sector.  This is in line with the requirements of the Competition and Markets Authority.
Current and planned activity: 
Amplitude pro enterprise™ is currently in a number of NHS Trusts. Please see below for examples of these trusts and the departments that are using the system:
 
Abertawe Bro Morgannwg University Health Board (Swansea) – All subspecialties
Aintree University Hospitals NHS Foundation Trust (Liverpool) – Foot & Ankle and Knee
Royal Orthopaedic Hospital (Birmingham) – Hip & Knee
Cardiff and Vale University Health Board (Cardiff) – Hip & Knee
Royal National Orthopaedic Hospital (London) – All subspecialties
Glasgow Royal Infirmary (Glasgow) - Shoulders
University Hospital Coventry (Coventry) – Department yet to be decided
Royal Berkshire Hospital NHS Foundation Trust (Reading) – Department yet to be decided

Amplitude is seeking support to further increase the adoption of pro enterprise™ within all trusts in the West Midlands and raise the awareness of pro enterprise™ software and the multiple uses for hospitals and trusts.
 
What is the intellectual property status of your innovation?:
Amplitude Clinical Services holds all intellectual property for the system code and integrity.
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
2 years
Ease of scalability: 
2
Read more
Hide details
Emily Burnett 25/04/2016 - 11:56 Publish Login or Register to post comments
0
0
Votes
-99999
Innovation 'Elevator Pitch':
DLS Access gives patients same-day access to their healthcare professionals via the web/smartphone/Skype or telephone achieving savings of £15 per patient with additional benefits.
Overview of Innovation:
DLS Access allows healthcare professionals to deal with increasing patient demand more efficiently and delivers a clear return on investment.  DLS Access is a cloud based service which is purchased on an annual per patient licence basis across the whole patient population.  The service is backed-up with executive level support and access to a DLS Client Delivery Manager to ensure successful deployment into your organisation.
 
Consultation requests are made by registered patients using their phone, a smartphone app or via a web form.  All requests are directed in to the ‘Health Hub’ and handled by trained call centre operatives.
 
The Health Hub team puts each patient on a call-back list for the requested healthcare professional who then aims to call the patient back within an hour, either by phone or Skype, whichever the patient requested.  This system provides same day primary care access for the group’s patient population, without opening for extended hours.  Out of hours demand is managed better and patients are seen quicker.
 
Results from the first deployment of DLS Access, which was through their partnership with Modality (previously Vitality) Partnership in the Prime Minister’s Wave 1 Challenge Fund programme have been more than hoped for.
 
DLS Access has demonstrated a £15 saving per patient across the group.
  • Over 65% of all health concerns are now dealt with remotely, within the hour.
  • Practices within the group have seen between 5-10% reduction in A&E attendance as a result of the DLS Access Service.
  • The Group have seen a 72% reduction in missed GP and ANP appointments. 
Many other benefits have been seen across Modality’s business as well as a return on investment from the savings the DLS Access project has achieved, these are outlined in the ‘Benefit to the NHS’ section below.
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Digital health / Person centred care
Benefit to NHS:
Results and benefits shown below have been tracked through Digital Life Sciences’ wave 1 Prime Minister’s Challenge Fund Programme, delivered in partnership with Modality (previously Vitality) Partnership between March 2013 and 2014.  The service continues to run, with the next steps of the digital strategy to be delivered through the Modality Vanguard programme.
 
The Modality Health Hub is one of the first truly digitally delivered primary care services and the first live example of how technology is enabling 65,000 patients to access their healthcare digitally.
 
DLS Access – Results for 65,000 patients
 
  • £15.49 saving per patient
  • 1600 patient hub contacts per day
  • 40 seconds average time calls are answered with in the Health Hub
  • 1,100 downloads of the Health Hub App to date
  • 400 website users per day
  • Over 4,000 registered online users
  • 68% of all health concerns are dealt with remotely within the hour
  • 32% of all patient demand now requires a face to face consultation
  • 72% reduction in missed GP and ANP appointments
  • Reduced consultation time – an average consultation is only 5 minutes, compared to the traditional 7 minute face to face consultation
  • Increased clinical capacity – early indications show up to a 10% increase in the number of patient consultations handled each day
  • Demand for appointments equalising – demand for appointments is equalising throughout the day and week, easing the historic 8am and Monday bottlenecks
  • Increasing online requests – an average of 50 online requests received per day with 28% received via the bespoke Android and iOS mobile apps 
“The new system is improving every day as patients and staff gets used to a different way of working.  Compared to the old system, I am able to speak to a greater number of patients per day and my patients only need to visit the surgery when absolutely necessary” – Dr Shaylor, Laurie Pike Health Centre
Initial Review Rating
5.00 (1 ratings)
Benefit to WM population:
The return on investment calculations for a DLS One Patient Access PMCF Wave 1 project, based on 65,000 patients (costs are based on a transformed operating and workforce model that incurs no additional cost, which can be achieved with clear leadership and a commitment to change across the project.
 
Annual savings for patient population:
DNA’s based on 72% reduction £209,950.00
A&E attendance based on 18% reduction £1,186,900.00
Total annual savings for patient population £1,396,850.00
 
Cost to install One Patient Access:
One Patient Access model of £5 per patient per annum £390,000.00
 
Return on Investment (shown as savings):
Return on investment for whole patient population £1,006,850.00
Per patient ROI £15.49
 
Many other benefits can be realised such as reduced consultation time, increased clinical capacity, demand for appointments equalising and an increase in online requests.
 
More information is available – click here.
 
“Just a quick note to congratulate you on the Modality Partnership app.  Personally, I think this is a great app which has allowed me to connect very easily and quickly to my doctor” – Modality Patient (comment from Modality Partnership website.
Current and planned activity: 
DLS Access is currently being rolled out to 'at scale' primary care providers including the South Worcestershire GP Federation and Aylesbury Vale GPs. The business is actively engaged in selling the service across the NHS.
What is the intellectual property status of your innovation?:
The I.P. is wholly owned by Digital Life Sciences Ltd
Return on Investment (£ Value): 
Very high
Return on Investment (Timescale): 
1 year
Ease of scalability: 
2
Read more
Hide details
Robin Vickers 01/03/2016 - 14:23 Publish Login or Register to post comments
6
4
Votes
-99999

Recent Activities

Clinical Research and Clinical Trial Collaborations has been moved from Initial Submission to Publish 1 week 14 hours ago
The Real Birth Online Workshop: addressing the barriers to effective antenatal education has been moved from Initial Submission to Publish 1 week 6 days ago
Elaine Russell commented on Cera Care 2 weeks 2 days ago
Elaine Russell commented on Cera Care 2 weeks 2 days ago
Ravi Kumar commented on Continuing Healthcare Workflow Software: CHC2DST to underpin service transformation 10 weeks 5 days ago

Active Campaigns